Biomarkers predict effectiveness of radiation treatments for cancer — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/03/140327123713.htm
source : http://www.sciencedaily.com/releases/2014/03/140327123713.htm
source : http://www.sciencedaily.com/releases/2014/02/140225193410.htm
source : http://www.sciencedaily.com/releases/2014/02/140225193412.htm
source : http://www.sciencedaily.com/releases/2014/01/140126134651.htm
Women diagnosed with vulvar cancer are often treated with surgery that involves the removal of substantial sections of the external genitalia. Because survival rates are extremely high for women with early stages of the disease, it is important to understand the psychosocial issues that women experience following treatment. Ellen Barlow, RN, of The Royal Hospital for Women in Australia, and her colleagues interviewed 10 women who had previously been treated for early stage vulvar cancer, with a focus on investigating the women’s experiences of sexuality and body image. The researchers found that the majority of women experienced little to no long-term disruption to sexuality and body image following conservative surgery to treat their cancer…
Sophisticated computer modelling could be used to slowly move the table — known as a couch — and a radiation source in three dimensions to direct radiation precisely to the patient’s tumor, researchers have suggested. At the moment, a radiotherapy table can be angled during treatment, but there is no way to synchronise its rotation with a moving radiation beam. But with some modifications, an upgraded system could move both the patient and the beam while reducing the radiation dose of healthy tissue…
These mutations are found in nearly 100 per cent of patients suffering from two rare bone tumours; chondroblastoma and giant cell tumour of the bone. Chondroblastoma and giant cell tumour of bone are benign bone tumours that primarily affect adolescents and young adults, respectively. They can be extremely debilitating tumours and recur despite surgery…
The research, published in the October issue of the journal Clinical Cancer Research, provides important evidence that PARP inhibitor drugs and chemotherapy can both be effective in the same patients, helping women live longer than they would if treated with chemotherapy alone. …
The new pilot study, published in the August issue of the Annals of Oncology, tested a new treatment in a pilot study of men with stage IIA and IIB testicular seminoma — where the cancer has spread to the lymph nodes in the abdomen. The researchers showed that giving chemotherapy drug carboplatin before radiotherapy could reduce relapse rates compared with radiotherapy alone — cutting the numbers of men who would need follow-up treatment. It also allowed radiation doses to be reduced. …
In addition to causing cervical, anal and genital cancers, HPV has more recently been found to cause some head and neck cancers. "One of the main issues is this form of esophageal cancer is usually diagnosed quite late and so has a very high mortality," says the first author of the paper, Dr Surabhi Liyanage, a PhD candidate with the School of Public Health and Community Medicine, UNSW Medicine…